CN Patent

CN114599374A — 用于增强抗癌化合物e7766的治疗依从性的系统

Assigned to Sanitary Material R&d Management Co ltd · Expires 2022-06-07 · 4y expired

What this patent protects

报告了用于减少用药错误并增强患有癌症的个体的治疗依从性的系统。对于可能与OATP抑制剂组合的抗癌治疗性化合物1(E7766)的剂量，实施例提供了关于药物‑药物相互作用的信息。

USPTO Abstract

报告了用于减少用药错误并增强患有癌症的个体的治疗依从性的系统。对于可能与OATP抑制剂组合的抗癌治疗性化合物1(E7766)的剂量，实施例提供了关于药物‑药物相互作用的信息。

Drugs covered by this patent

Patent Metadata

Patent number
CN114599374A
Jurisdiction
CN
Classification
—
Expires
2022-06-07
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.